Cellares

Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated Development and Manufacturing Organization (IDMO).

Founded in 2019, Cellares employs an Industry 4.0 approach to mass-manufacture living cell therapies using fully automated and scalable platforms. The company focuses on enabling drug sponsors to develop, scale, and commercialize cell therapies efficiently to meet global patient demand. Cellares offers end-to-end cell therapy development and manufacturing services, addressing production bottlenecks that can delay patient access to FDA-approved treatments. Key offerings include the Cell ShuttleTM, an automated platform for producing suspension-based cell therapies, and Cell QTM, a quality control system that ensures compliance and reproducibility. The company operates globally with purpose-built Smart Factories that significantly enhance throughput and reduce costs compared to traditional models. Cellares serves a range of B2B clients, including major pharmaceutical firms, biotechnology companies, and academic institutions, all seeking to scale their cell therapy production.